Johnson Robert Matthew
Known title: DirectorCIK: 0001792014
Associated companies
Transaction History
| NOVT | ▲ Buy | Option Exercise | 1,325 | — | 1/2/2026 | View on chart |
| NOVT | ▲ Buy | Option Exercise | 818 | — | 5/8/2025 | View on chart |
| NOVT | ▲ Buy | Option Exercise | 1,325 | — | 1/2/2026 | View on chart |
| NOVT | ▲ Buy | Option Exercise | 818 | — | 5/8/2025 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Novanta Shares Rise Amid Positive Analyst Mentions
Recent reports highlight Novanta as a stock gaining attention from Wall Street, with one article noting its shares skyrocketed alongside other names. The company is currently trading near its 52-week low, despite analysts maintaining a higher average target price. This divergence suggests the market is currently pricing in significant caution regarding the stock's high valuation.
Novanta Shares Rise Amid Positive Analyst Mentions. Recent reports highlight Novanta as a stock gaining attention from Wall Street, with one article noting its shares skyrocketed alongside other names. The company is currently trading near its 52-week low, despite analysts maintaining a higher average target price. This divergence suggests the market is currently pricing in significant caution regarding the stock's high valuation.